The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Livestock Vaccines Market Research Report 2025
Synopsis
The global Livestock Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Livestock Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Livestock Vaccines.
Report Scope
The Livestock Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Livestock Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Livestock Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Boehringer Ingelheim
Ceva
Zoetis
Vaxxinova®
Elanco
QYH Biotech Co., Ltd
Pulike
Phibro Animal Health Corporation
JinYu Biotechnology
Harbin Pharmaceutical Group
MEVAC
Venky's
Japfa Comfeed Indonesia
Nisseiken
Hile
Hester Biosciences
Segment by Type
Foot and Mouth Disease Vaccine
Pig Ring Vaccine
Bird Flu Vaccine
Porcine Blue Ear Vaccine
Swine Fever Vaccine
Segment by Application
Pig
Cattle and Sheep
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Livestock Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Livestock Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Livestock Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Livestock Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Livestock Vaccines.
Report Scope
The Livestock Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Livestock Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Livestock Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Boehringer Ingelheim
Ceva
Zoetis
Vaxxinova®
Elanco
QYH Biotech Co., Ltd
Pulike
Phibro Animal Health Corporation
JinYu Biotechnology
Harbin Pharmaceutical Group
MEVAC
Venky's
Japfa Comfeed Indonesia
Nisseiken
Hile
Hester Biosciences
Segment by Type
Foot and Mouth Disease Vaccine
Pig Ring Vaccine
Bird Flu Vaccine
Porcine Blue Ear Vaccine
Swine Fever Vaccine
Segment by Application
Pig
Cattle and Sheep
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Livestock Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Livestock Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Livestock Vaccines Market Overview
1.1 Product Overview and Scope of Livestock Vaccines
1.2 Livestock Vaccines Segment by Type
1.2.1 Global Livestock Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Foot and Mouth Disease Vaccine
1.2.3 Pig Ring Vaccine
1.2.4 Bird Flu Vaccine
1.2.5 Porcine Blue Ear Vaccine
1.2.6 Swine Fever Vaccine
1.3 Livestock Vaccines Segment by Application
1.3.1 Global Livestock Vaccines Market Value by Application: (2024-2030)
1.3.2 Pig
1.3.3 Cattle and Sheep
1.3.4 Others
1.4 Global Livestock Vaccines Market Size Estimates and Forecasts
1.4.1 Global Livestock Vaccines Revenue 2019-2030
1.4.2 Global Livestock Vaccines Sales 2019-2030
1.4.3 Global Livestock Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Livestock Vaccines Market Competition by Manufacturers
2.1 Global Livestock Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Livestock Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Livestock Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Livestock Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Livestock Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Livestock Vaccines, Product Type & Application
2.7 Livestock Vaccines Market Competitive Situation and Trends
2.7.1 Livestock Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Livestock Vaccines Players Market Share by Revenue
2.7.3 Global Livestock Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Livestock Vaccines Retrospective Market Scenario by Region
3.1 Global Livestock Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Livestock Vaccines Global Livestock Vaccines Sales by Region: 2019-2030
3.2.1 Global Livestock Vaccines Sales by Region: 2019-2024
3.2.2 Global Livestock Vaccines Sales by Region: 2025-2030
3.3 Global Livestock Vaccines Global Livestock Vaccines Revenue by Region: 2019-2030
3.3.1 Global Livestock Vaccines Revenue by Region: 2019-2024
3.3.2 Global Livestock Vaccines Revenue by Region: 2025-2030
3.4 North America Livestock Vaccines Market Facts & Figures by Country
3.4.1 North America Livestock Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Livestock Vaccines Sales by Country (2019-2030)
3.4.3 North America Livestock Vaccines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Livestock Vaccines Market Facts & Figures by Country
3.5.1 Europe Livestock Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Livestock Vaccines Sales by Country (2019-2030)
3.5.3 Europe Livestock Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Livestock Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Livestock Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Livestock Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Livestock Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Livestock Vaccines Market Facts & Figures by Country
3.7.1 Latin America Livestock Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Livestock Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Livestock Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Livestock Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Livestock Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Livestock Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Livestock Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Livestock Vaccines Sales by Type (2019-2030)
4.1.1 Global Livestock Vaccines Sales by Type (2019-2024)
4.1.2 Global Livestock Vaccines Sales by Type (2025-2030)
4.1.3 Global Livestock Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Livestock Vaccines Revenue by Type (2019-2030)
4.2.1 Global Livestock Vaccines Revenue by Type (2019-2024)
4.2.2 Global Livestock Vaccines Revenue by Type (2025-2030)
4.2.3 Global Livestock Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Livestock Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Livestock Vaccines Sales by Application (2019-2030)
5.1.1 Global Livestock Vaccines Sales by Application (2019-2024)
5.1.2 Global Livestock Vaccines Sales by Application (2025-2030)
5.1.3 Global Livestock Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Livestock Vaccines Revenue by Application (2019-2030)
5.2.1 Global Livestock Vaccines Revenue by Application (2019-2024)
5.2.2 Global Livestock Vaccines Revenue by Application (2025-2030)
5.2.3 Global Livestock Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Livestock Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Livestock Vaccines Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Corporation Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boehringer Ingelheim Livestock Vaccines Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 Ceva
6.3.1 Ceva Corporation Information
6.3.2 Ceva Description and Business Overview
6.3.3 Ceva Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Ceva Livestock Vaccines Product Portfolio
6.3.5 Ceva Recent Developments/Updates
6.4 Zoetis
6.4.1 Zoetis Corporation Information
6.4.2 Zoetis Description and Business Overview
6.4.3 Zoetis Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zoetis Livestock Vaccines Product Portfolio
6.4.5 Zoetis Recent Developments/Updates
6.5 Vaxxinova®
6.5.1 Vaxxinova® Corporation Information
6.5.2 Vaxxinova® Description and Business Overview
6.5.3 Vaxxinova® Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Vaxxinova® Livestock Vaccines Product Portfolio
6.5.5 Vaxxinova® Recent Developments/Updates
6.6 Elanco
6.6.1 Elanco Corporation Information
6.6.2 Elanco Description and Business Overview
6.6.3 Elanco Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Elanco Livestock Vaccines Product Portfolio
6.6.5 Elanco Recent Developments/Updates
6.7 QYH Biotech Co., Ltd
6.6.1 QYH Biotech Co., Ltd Corporation Information
6.6.2 QYH Biotech Co., Ltd Description and Business Overview
6.6.3 QYH Biotech Co., Ltd Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 QYH Biotech Co., Ltd Livestock Vaccines Product Portfolio
6.7.5 QYH Biotech Co., Ltd Recent Developments/Updates
6.8 Pulike
6.8.1 Pulike Corporation Information
6.8.2 Pulike Description and Business Overview
6.8.3 Pulike Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Pulike Livestock Vaccines Product Portfolio
6.8.5 Pulike Recent Developments/Updates
6.9 Phibro Animal Health Corporation
6.9.1 Phibro Animal Health Corporation Corporation Information
6.9.2 Phibro Animal Health Corporation Description and Business Overview
6.9.3 Phibro Animal Health Corporation Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Phibro Animal Health Corporation Livestock Vaccines Product Portfolio
6.9.5 Phibro Animal Health Corporation Recent Developments/Updates
6.10 JinYu Biotechnology
6.10.1 JinYu Biotechnology Corporation Information
6.10.2 JinYu Biotechnology Description and Business Overview
6.10.3 JinYu Biotechnology Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 JinYu Biotechnology Livestock Vaccines Product Portfolio
6.10.5 JinYu Biotechnology Recent Developments/Updates
6.11 Harbin Pharmaceutical Group
6.11.1 Harbin Pharmaceutical Group Corporation Information
6.11.2 Harbin Pharmaceutical Group Livestock Vaccines Description and Business Overview
6.11.3 Harbin Pharmaceutical Group Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Harbin Pharmaceutical Group Livestock Vaccines Product Portfolio
6.11.5 Harbin Pharmaceutical Group Recent Developments/Updates
6.12 MEVAC
6.12.1 MEVAC Corporation Information
6.12.2 MEVAC Livestock Vaccines Description and Business Overview
6.12.3 MEVAC Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.12.4 MEVAC Livestock Vaccines Product Portfolio
6.12.5 MEVAC Recent Developments/Updates
6.13 Venky's
6.13.1 Venky's Corporation Information
6.13.2 Venky's Livestock Vaccines Description and Business Overview
6.13.3 Venky's Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Venky's Livestock Vaccines Product Portfolio
6.13.5 Venky's Recent Developments/Updates
6.14 Japfa Comfeed Indonesia
6.14.1 Japfa Comfeed Indonesia Corporation Information
6.14.2 Japfa Comfeed Indonesia Livestock Vaccines Description and Business Overview
6.14.3 Japfa Comfeed Indonesia Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Japfa Comfeed Indonesia Livestock Vaccines Product Portfolio
6.14.5 Japfa Comfeed Indonesia Recent Developments/Updates
6.15 Nisseiken
6.15.1 Nisseiken Corporation Information
6.15.2 Nisseiken Livestock Vaccines Description and Business Overview
6.15.3 Nisseiken Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Nisseiken Livestock Vaccines Product Portfolio
6.15.5 Nisseiken Recent Developments/Updates
6.16 Hile
6.16.1 Hile Corporation Information
6.16.2 Hile Livestock Vaccines Description and Business Overview
6.16.3 Hile Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Hile Livestock Vaccines Product Portfolio
6.16.5 Hile Recent Developments/Updates
6.17 Hester Biosciences
6.17.1 Hester Biosciences Corporation Information
6.17.2 Hester Biosciences Livestock Vaccines Description and Business Overview
6.17.3 Hester Biosciences Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Hester Biosciences Livestock Vaccines Product Portfolio
6.17.5 Hester Biosciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Livestock Vaccines Industry Chain Analysis
7.2 Livestock Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Livestock Vaccines Production Mode & Process
7.4 Livestock Vaccines Sales and Marketing
7.4.1 Livestock Vaccines Sales Channels
7.4.2 Livestock Vaccines Distributors
7.5 Livestock Vaccines Customers
8 Livestock Vaccines Market Dynamics
8.1 Livestock Vaccines Industry Trends
8.2 Livestock Vaccines Market Drivers
8.3 Livestock Vaccines Market Challenges
8.4 Livestock Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Livestock Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Livestock Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Livestock Vaccines Market Competitive Situation by Manufacturers in 2023
Table 4. Global Livestock Vaccines Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Livestock Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Livestock Vaccines Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Livestock Vaccines Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Livestock Vaccines Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Livestock Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Livestock Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Livestock Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Livestock Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Livestock Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Livestock Vaccines as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Livestock Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Livestock Vaccines Sales by Region (2019-2024) & (K Units)
Table 18. Global Livestock Vaccines Sales Market Share by Region (2019-2024)
Table 19. Global Livestock Vaccines Sales by Region (2025-2030) & (K Units)
Table 20. Global Livestock Vaccines Sales Market Share by Region (2025-2030)
Table 21. Global Livestock Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Livestock Vaccines Revenue Market Share by Region (2019-2024)
Table 23. Global Livestock Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Livestock Vaccines Revenue Market Share by Region (2025-2030)
Table 25. North America Livestock Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Livestock Vaccines Sales by Country (2019-2024) & (K Units)
Table 27. North America Livestock Vaccines Sales by Country (2025-2030) & (K Units)
Table 28. North America Livestock Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Livestock Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Livestock Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Livestock Vaccines Sales by Country (2019-2024) & (K Units)
Table 32. Europe Livestock Vaccines Sales by Country (2025-2030) & (K Units)
Table 33. Europe Livestock Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Livestock Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Livestock Vaccines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Livestock Vaccines Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Livestock Vaccines Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Livestock Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Livestock Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Livestock Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Livestock Vaccines Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Livestock Vaccines Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Livestock Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Livestock Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Livestock Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Livestock Vaccines Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Livestock Vaccines Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Livestock Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Livestock Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Livestock Vaccines Sales (K Units) by Type (2019-2024)
Table 51. Global Livestock Vaccines Sales (K Units) by Type (2025-2030)
Table 52. Global Livestock Vaccines Sales Market Share by Type (2019-2024)
Table 53. Global Livestock Vaccines Sales Market Share by Type (2025-2030)
Table 54. Global Livestock Vaccines Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Livestock Vaccines Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Livestock Vaccines Revenue Market Share by Type (2019-2024)
Table 57. Global Livestock Vaccines Revenue Market Share by Type (2025-2030)
Table 58. Global Livestock Vaccines Price (US$/Unit) by Type (2019-2024)
Table 59. Global Livestock Vaccines Price (US$/Unit) by Type (2025-2030)
Table 60. Global Livestock Vaccines Sales (K Units) by Application (2019-2024)
Table 61. Global Livestock Vaccines Sales (K Units) by Application (2025-2030)
Table 62. Global Livestock Vaccines Sales Market Share by Application (2019-2024)
Table 63. Global Livestock Vaccines Sales Market Share by Application (2025-2030)
Table 64. Global Livestock Vaccines Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Livestock Vaccines Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Livestock Vaccines Revenue Market Share by Application (2019-2024)
Table 67. Global Livestock Vaccines Revenue Market Share by Application (2025-2030)
Table 68. Global Livestock Vaccines Price (US$/Unit) by Application (2019-2024)
Table 69. Global Livestock Vaccines Price (US$/Unit) by Application (2025-2030)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Livestock Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Merck Livestock Vaccines Product
Table 74. Merck Recent Developments/Updates
Table 75. Boehringer Ingelheim Corporation Information
Table 76. Boehringer Ingelheim Description and Business Overview
Table 77. Boehringer Ingelheim Livestock Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Boehringer Ingelheim Livestock Vaccines Product
Table 79. Boehringer Ingelheim Recent Developments/Updates
Table 80. Ceva Corporation Information
Table 81. Ceva Description and Business Overview
Table 82. Ceva Livestock Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Ceva Livestock Vaccines Product
Table 84. Ceva Recent Developments/Updates
Table 85. Zoetis Corporation Information
Table 86. Zoetis Description and Business Overview
Table 87. Zoetis Livestock Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Zoetis Livestock Vaccines Product
Table 89. Zoetis Recent Developments/Updates
Table 90. Vaxxinova® Corporation Information
Table 91. Vaxxinova® Description and Business Overview
Table 92. Vaxxinova® Livestock Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Vaxxinova® Livestock Vaccines Product
Table 94. Vaxxinova® Recent Developments/Updates
Table 95. Elanco Corporation Information
Table 96. Elanco Description and Business Overview
Table 97. Elanco Livestock Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Elanco Livestock Vaccines Product
Table 99. Elanco Recent Developments/Updates
Table 100. QYH Biotech Co., Ltd Corporation Information
Table 101. QYH Biotech Co., Ltd Description and Business Overview
Table 102. QYH Biotech Co., Ltd Livestock Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. QYH Biotech Co., Ltd Livestock Vaccines Product
Table 104. QYH Biotech Co., Ltd Recent Developments/Updates
Table 105. Pulike Corporation Information
Table 106. Pulike Description and Business Overview
Table 107. Pulike Livestock Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Pulike Livestock Vaccines Product
Table 109. Pulike Recent Developments/Updates
Table 110. Phibro Animal Health Corporation Corporation Information
Table 111. Phibro Animal Health Corporation Description and Business Overview
Table 112. Phibro Animal Health Corporation Livestock Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Phibro Animal Health Corporation Livestock Vaccines Product
Table 114. Phibro Animal Health Corporation Recent Developments/Updates
Table 115. JinYu Biotechnology Corporation Information
Table 116. JinYu Biotechnology Description and Business Overview
Table 117. JinYu Biotechnology Livestock Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. JinYu Biotechnology Livestock Vaccines Product
Table 119. JinYu Biotechnology Recent Developments/Updates
Table 120. Harbin Pharmaceutical Group Corporation Information
Table 121. Harbin Pharmaceutical Group Description and Business Overview
Table 122. Harbin Pharmaceutical Group Livestock Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Harbin Pharmaceutical Group Livestock Vaccines Product
Table 124. Harbin Pharmaceutical Group Recent Developments/Updates
Table 125. MEVAC Corporation Information
Table 126. MEVAC Description and Business Overview
Table 127. MEVAC Livestock Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. MEVAC Livestock Vaccines Product
Table 129. MEVAC Recent Developments/Updates
Table 130. Venky's Corporation Information
Table 131. Venky's Description and Business Overview
Table 132. Venky's Livestock Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Venky's Livestock Vaccines Product
Table 134. Venky's Recent Developments/Updates
Table 135. Japfa Comfeed Indonesia Corporation Information
Table 136. Japfa Comfeed Indonesia Description and Business Overview
Table 137. Japfa Comfeed Indonesia Livestock Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Japfa Comfeed Indonesia Livestock Vaccines Product
Table 139. Japfa Comfeed Indonesia Recent Developments/Updates
Table 140. Nisseiken Corporation Information
Table 141. Nisseiken Description and Business Overview
Table 142. Nisseiken Livestock Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Nisseiken Livestock Vaccines Product
Table 144. Nisseiken Recent Developments/Updates
Table 145. Hile Corporation Information
Table 146. Hile Description and Business Overview
Table 147. Hile Livestock Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Hile Livestock Vaccines Product
Table 149. Hile Recent Developments/Updates
Table 150. Hester Biosciences Corporation Information
Table 151. Hester Biosciences Description and Business Overview
Table 152. Hester Biosciences Livestock Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Hester Biosciences Livestock Vaccines Product
Table 154. Hester Biosciences Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Livestock Vaccines Distributors List
Table 158. Livestock Vaccines Customers List
Table 159. Livestock Vaccines Market Trends
Table 160. Livestock Vaccines Market Drivers
Table 161. Livestock Vaccines Market Challenges
Table 162. Livestock Vaccines Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Livestock Vaccines
Figure 2. Global Livestock Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Livestock Vaccines Market Share by Type in 2023 & 2030
Figure 4. Foot and Mouth Disease Vaccine Product Picture
Figure 5. Pig Ring Vaccine Product Picture
Figure 6. Bird Flu Vaccine Product Picture
Figure 7. Porcine Blue Ear Vaccine Product Picture
Figure 8. Swine Fever Vaccine Product Picture
Figure 9. Global Livestock Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Livestock Vaccines Market Share by Application in 2023 & 2030
Figure 11. Pig
Figure 12. Cattle and Sheep
Figure 13. Others
Figure 14. Global Livestock Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Livestock Vaccines Market Size (2019-2030) & (US$ Million)
Figure 16. Global Livestock Vaccines Sales (2019-2030) & (K Units)
Figure 17. Global Livestock Vaccines Average Price (US$/Unit) & (2019-2030)
Figure 18. Livestock Vaccines Report Years Considered
Figure 19. Livestock Vaccines Sales Share by Manufacturers in 2023
Figure 20. Global Livestock Vaccines Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Livestock Vaccines Players: Market Share by Revenue in 2023
Figure 22. Livestock Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Livestock Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Livestock Vaccines Sales Market Share by Country (2019-2030)
Figure 25. North America Livestock Vaccines Revenue Market Share by Country (2019-2030)
Figure 26. U.S. Livestock Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Livestock Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Livestock Vaccines Sales Market Share by Country (2019-2030)
Figure 29. Europe Livestock Vaccines Revenue Market Share by Country (2019-2030)
Figure 30. Germany Livestock Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Livestock Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Livestock Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Livestock Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Livestock Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Livestock Vaccines Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Livestock Vaccines Revenue Market Share by Region (2019-2030)
Figure 37. China Livestock Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Livestock Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Livestock Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Livestock Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Livestock Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Taiwan Livestock Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Indonesia Livestock Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Thailand Livestock Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Malaysia Livestock Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Philippines Livestock Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Latin America Livestock Vaccines Sales Market Share by Country (2019-2030)
Figure 48. Latin America Livestock Vaccines Revenue Market Share by Country (2019-2030)
Figure 49. Mexico Livestock Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Brazil Livestock Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Argentina Livestock Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Middle East & Africa Livestock Vaccines Sales Market Share by Country (2019-2030)
Figure 53. Middle East & Africa Livestock Vaccines Revenue Market Share by Country (2019-2030)
Figure 54. Turkey Livestock Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Livestock Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. U.A.E Livestock Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Global Sales Market Share of Livestock Vaccines by Type (2019-2030)
Figure 58. Global Revenue Market Share of Livestock Vaccines by Type (2019-2030)
Figure 59. Global Livestock Vaccines Price (US$/Unit) by Type (2019-2030)
Figure 60. Global Sales Market Share of Livestock Vaccines by Application (2019-2030)
Figure 61. Global Revenue Market Share of Livestock Vaccines by Application (2019-2030)
Figure 62. Global Livestock Vaccines Price (US$/Unit) by Application (2019-2030)
Figure 63. Livestock Vaccines Value Chain
Figure 64. Livestock Vaccines Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
